In this presentation, Dr Strober provides us with new data on TNF alpha inhibition in the treatment of hidradenitis suppurativa (HS). HS is sometimes referred to as acne inversa; however, Dr Strober feels it is a different disease based upon a lot of lines of evidence.Based on recent insights into the pathogenesis of this disease, TNF inhibition has found to be an effective treatment. Essentially, it’s phenomenological, because if you look at lesional skin, there is more TNF alpha as compared to peri-lesional as compared to control skin. This isn’t to say that TNF is the only relevant cytokine; in fact, it may be the first of many which will be targeted over the next decade. Just like in psoriasis, TNF will be the first cytokine studied for targeting in HS.Dermatology Treatment
TNF-a Inhibition and the Treatment of Hidradenitis Suppurativa – Maui Derm
- , Research, Comorbidity, 0
What are spondyloarthropathies? Spondyloarthropathies are a family of long-term (chronic) diseases of joints. These diseases occur in children (juvenile...
- , Research, 0
THE AMMAR-KHODJA PROFESSOR IN THE NEWS New approach to fight disease Physicians are invited to discover an innovative theme...
- , PUBMED Research, Research, 0
Journal: JAMA Dermatol 2016 Nov;152(11):1276-1278 Author(s): Haskin A, Fischer AH, Okoye GA Dermatology Journal and/or Publisher Journal Name: JAMA...
- , Research, 0
The Center for Rare Disease Therapy at Children’s Hospital of Pittsburgh of UPMC consists of international experts focused on...
Hidradenitis suppurativa (HS) Non-Profit (501c3) 2017 Registration
We are currently fundraising for the Non-Profit (501c3) registration of HSAWARENESS.ORG and our growing NGO at large. We cannot realize this next and essential step for our critical work without you.
“I WILL NOT HIDE” Hidradenitis suppurativa (HS) Patient Stories Book Series
The “I WILL NOT HIDE” Hidradenitis Suppurativa book series is now available. These patient story volumes tell the stories of Hidradenitis Suppurativa (HS) patients in vivid and personal narrative. Told by HS patients themselves.
HSAWARENESS EMAIL UPDATES
Join our mailing list to learn more about the measurable results being made for the patients of rare and orphan disease communities.